Boston Patent Law Association Announces Support for IPO-AIPLA Section 101 Legislative Fix
Boston Patent Law Association Announces Support for IPO-AIPLA Section 101 Legislative Fix IPWatchdog.com Full coverage
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Off-patent drug appears promising as broad-spectrum antifungal
Off-patent drug appears promising as broad-spectrum antifungal Science Daily Full coverage
-
In: PATENT NEWS
For Motorola, patents provide the sword and the shield
For Motorola, patents provide the sword and the shield Crain’s Chicago Business Full coverage
-
In: PATENT NEWS
NarrativeDx Awarded Patent for Patient Feedback Analysis
NarrativeDx Awarded Patent for Patient Feedback Analysis PR Newswire (press release) Full coverage
-
In: PATENT NEWS
Some Causes and Cures for High Drug Prices
Our patent laws grant market monopolies and our taxes directly fund much of the scientific research underlying medical advances, but our federal …
-
In: PATENT NEWS
Asia Tour Yields New Opportunities
Beijing – China University of Political Science and Law … is for Chinese companies, if we have patent rights in the rest of the world, but not in China.
-
In: PATENT NEWS
Court gives Digital Ally another win, rejects Taser’s last-ditch legal move
Digital Ally, which developed cameras for law enforcement, has been engaged in a legal battle with Axon over its intellectual property for about three …
-
In: PATENT NEWS
Universities and patents
On October 28, the Central government conducted the competitive examination to test proficiency in patent law, a type of intellectual property right …
-
In: PATENT NEWS
MedMen Seeks Trademark for Word ‘Cannabis’ Appearing On T-Shirts
Michael Brubaker, a Seattle patent attorney, put it bluntly, telling Leafly that, “Trying to trademark ‘cannabis’ is a fool’s errand. I give it a zero percent …
-
In: PATENT NEWS
Apotex not permitted to plead promise-based invalidity grounds in Ontario section 8 lansoprazole …
Apotex in turn has challenged the validity of Takeda’s patents. … of patent invalidity, deferring to the Federal Court as a specialist bench in patent law.